Antimicrobial Stewardship Program Practice Test

The World Health Organization (WHO) categorizes antimicrobials primarily by drug class. This classification is crucial for understanding the spectrum of activity of different antimicrobials and their mechanisms of action. By organizing these medications into specific classes, the WHO aids healthcare professionals in making informed decisions about which antimicrobial to use based on the type of infection, the causative organism, and the specific resistance patterns seen in their practice.

Organizing antimicrobials by drug class also helps in promoting the appropriate use of these medications and supports antimicrobial stewardship efforts. This strategy emphasizes the need for careful selection and use of antimicrobials to combat resistance and ensure effective treatment options remain available. The classification also enables healthcare providers to have a clearer understanding of potential cross-resistance among different drugs within the same class.

Using market price, effectiveness, or manufacturer as categorization criteria does not provide the systematic approach needed for understanding how these drugs work, the resistance they may encounter, or how they can be effectively used in clinical practice. By focusing on drug classes, the WHO creates a more cohesive framework for defining and managing antimicrobial use globally.